Avant Technologies expands joint venture territory to global license; extends conditions deadline to Nov 2025

AVAI BIO, INC.

Addendum expands Ainnova’s Technology Portfolio license to global territory (previously North America and Europe).
Conditions satisfaction deadline under Joint Venture Agreement extended from May 8, 2025 to November 8, 2025.
Parties agree to possible merger terms as per Term Sheet signed September 21, 2024.
Ai-nova Acquisition Corp, LLC formed December 6, 2024; jointly represented by CEOs of Avant and Ainnova.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.